SYNACT PHARMA ApS
Clinical-stage biotech company developing innovative therapies to resolve inflammation.
Overview
- 6
- Employees
- Unknown
- Revenue
- 2012
- Founded
Key Decision Makers
Ann Kristin Led
Chief Financial Officer
Jeppe Øvlesen
Chief Executive Officer
Roy Fleischmann
Advisory Board Member
Ravi Rao
Advisory Board Member
+14 more contacts in Funnelfeedr
Description
SynAct Pharma is a clinical-stage biotechnology company based in Sweden and Denmark that focuses on developing innovative therapies to resolve inflammation rather than simply inhibiting it. Their lead drug candidate, Resomelagon (AP1189), is a once-daily oral therapy designed to selectively activate...